A Rho-kinase inhibitor improves cardiac function after 24-hour heart preservation  Mariko Kobayashi, MD, Yoshihisa Tanoue, MD, Masataka Eto, MD, Hironori.

Slides:



Advertisements
Similar presentations
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Advertisements

Of mice and men and surgical transcatheter aortic valve insertion
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
Surgery for congenital diseases of the aorta
Long-acting oral phosphodiesterase inhibition preconditions against reperfusion injury in an experimental lung transplantation model  Eric S. Weiss, MD,
Protective effects of cold spinoplegia with fasudil against ischemic spinal cord injury in rabbits  Hironori Baba, MD, Yoshihisa Tanoue, MD, PhD, Taketoshi.
The days of future past  Neel K. Ranganath, MD, Aubrey C. Galloway, MD 
Building a bioartificial heart: A 3-song saga
Ground glass opacity of the lung: The veil that needs lifting
Personalized cardiac surgery: Can noninvasive flow imaging lead to individualized resection strategies for bicuspid aortopathy?  Nicholas D. Andersen,
Murray H. Kwon, MD  The Journal of Thoracic and Cardiovascular Surgery 
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Form ever follows function
William M. DeCampli, MD, PhD 
Application of a neuroscience research model to study neuroprotection in children with congenital heart disease  Nobuyuki Ishibashi, MD, Richard A. Jonas,
Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 
Bicuspid aortic valve aortopathy: One size fits all?
Single-dose rosuvastatin ameliorates lung ischemia–reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage.
Cold blood cardioplegia reduces the increase in cardiac enzyme levels compared with cold crystalloid cardioplegia in patients undergoing aortic valve.
The lord of the rings  Antonio Miceli, MD, PhD 
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Myocyte and endothelial effects of preconditioning the jeopardized heart by inhibiting Na+/H+ exchange  Manuel Castellá, MDa, Gerald D. Buckberg, MDa,
Juan N. Pulido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Michael Mack, MD, David Taggart, MD 
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Fixing the supply problem
Military surgeons just want to have fun
A first start for lung transplantation?
Ischemic preconditioning with opening of mitochondrial adenosine triphosphate– sensitive potassium channels or Na+/H+ exchange inhibition: Which is the.
Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc 
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Leora B. Balsam, MD, Abe DeAnda, MD 
Niv Ad, MD, Lawrence M. Wei, MD 
Guidelines should bother us, not comfort us
Left atrial pressure measurement in a rat is currently impossible due to size limitations of balloon occlusion catheter  Filip Konecny, MSc, DVM, PhD 
Replicating the success of mitral valve repair in the aortic valve
Fueling the heart: Shifting the myocardial metabolome by targeting endothelial autophagy  Nicholas D. Andersen, MD  The Journal of Thoracic and Cardiovascular.
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD 
T. Brett Reece, MD  The Journal of Thoracic and Cardiovascular Surgery 
Hans-Joachim Schäfers, MD 
Ralph S. Mosca, MD  The Journal of Thoracic and Cardiovascular Surgery 
Innovation in cardiothoracic surgical training
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Early extubation after cardiac surgery: The evolution continues
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Keep it short and sweet  Ian A. Makey, MD, Scott B. Johnson, MD 
The future of cardiac surgery training: A survival guide
The continuing challenge of congenital heart disease in China
Between a rock and a hard place
High-dose atorvastatin is associated with impaired myocardial angiogenesis in response to vascular endothelial growth factor in hypercholesterolemic swine 
“The more things change…”: The challenges ahead
Commentary: Judgment day: Should you add atrial fibrillation ablation?
Why arch curvature affects arch resistance
Toward a more rational approach in treating type B aortic dissection
Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know  Harold L. Lazar,
Toll-like receptor 4 inhibition attenuates ischemia-reperfusion injury in rats: Will it work in human beings?  Chadrick E. Denlinger, MD  The Journal.
Nitroglycerin as a nitric oxide donor accelerates lipid peroxidation but preserves ventricular function in a canine model of orthotopic heart transplantation 
Commentary: Just say NO
Preoperative PFTs: The answer is blowing in the wind
The evolution of cardiothoracic critical care
Perioperative renal function and thoracoabdominal aneurysm repair: Where do we go from here?  Leonard N. Girardi, MD  The Journal of Thoracic and Cardiovascular.
Sunjay Kaushal, MD, PhD, Brody Wehman, MD 
Journal changes and initiatives
Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”
Zone zero thoracic endovascular aortic repair is all about “location, location, location”  Kevin L. Greason, MD  The Journal of Thoracic and Cardiovascular.
Calpain inhibitors: The aspirin of the 21st century?
Presentation transcript:

A Rho-kinase inhibitor improves cardiac function after 24-hour heart preservation  Mariko Kobayashi, MD, Yoshihisa Tanoue, MD, Masataka Eto, MD, Hironori Baba, MD, Satoshi Kimura, MD, Shinichiro Oda, MD, Kenichiro Taniguchi, MD, Ryuji Tominaga, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 136, Issue 6, Pages 1586-1592 (December 2008) DOI: 10.1016/j.jtcvs.2008.07.038 Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Modified Frank–Starling curves obtained by means of multiple regression analysis with dummy variables in each group. The black broken lines show the individual curves in each group. The black solid lines represent the regression equations for each curve. Representative equations are as follows: (A) y = −2.01 x2 + 36.75 x −19.85 at 60 minutes in the control group; (B) y = −5.91 x2 + 62.08 x +18.13 at 60 minutes in the Rho-kinase inhibitor group; (C) y = −0.16 x2 + 19.05 x + 27.24 at 120 minutes in the control group; (D) y = −5.49 x2 + 63.44 x −3.74 at 120 minutes in the Rho-kinase inhibitor group. The values of the x-intercept and the slope at the x-intercept obtained from individual curves in each group are shown in Table 1. AoF, Aortic flow; LAP, left atrial pressure. The Journal of Thoracic and Cardiovascular Surgery 2008 136, 1586-1592DOI: (10.1016/j.jtcvs.2008.07.038) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 A, Maximum coronary blood flow (CBF) after reperfusion. The CBF rate was higher in the Rho-kinase inhibitor (RKI) group than in the control group at both 10 and 120 minutes (∗P < .05). B, Heart rate (HR) of the donor in each group after reperfusion. The HR in the RKI group was more similar to normal levels compared with that in the control group. HR at 120 minutes was significantly higher in the RKI group than in the control group (∗P < .05, #P = .08). The Journal of Thoracic and Cardiovascular Surgery 2008 136, 1586-1592DOI: (10.1016/j.jtcvs.2008.07.038) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 A, Comparison of creatine kinase−MB (CK-MB) levels at 120 minutes with those at 60 minutes. Rate of change in CK-MB level in the control group was 256.19% ± 125.15%, whereas that in the Rho-kinase inhibitor (RKI) group was 132.89% ± 17.40% (∗P < .05). B, Relative expression of endothelial nitric oxide synthase (eNOS) mRNA in the control and RKI groups. eNOS expression in the RKI group was 4-fold higher than that in the control group. C, Suppression of phosphorylated myosin light chain (p-MLC) by RKI. The extent of p-MLC was significantly inhibited in the RKI group compared with that in the control group (33.82% ± 11.37% vs 7.26% ± 2.31%, ∗P < .05). The Journal of Thoracic and Cardiovascular Surgery 2008 136, 1586-1592DOI: (10.1016/j.jtcvs.2008.07.038) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions